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 ABSTRACT 1 
The p22
phox
 protein is an essential component of the phagocytic- and inner ear NADPH oxidases but its 2 
relationship to other Nox proteins is less clear. We have studied the role of p22
phox
 in the TGF-β1-3 
stimulated H2O2 production of primary human and murine fibroblasts. TGF-β1 induced H2O2 release of 4 
the examined cells, and the response was dependent on the expression of both Nox4 and p22
phox
. 5 
Interestingly, the p22
phox
 protein was present in the absence of any detectable Nox/Duox expression, and 6 
the p22
phox
 level was unaffected by TGF-β1. On the other hand, Nox4 expression was dependent on the 7 
presence of p22
phox
, establishing an asymmetrical relationship between the two proteins. Nox4 and p22
phox
 8 
proteins localized to the endoplasmic reticulum and their distribution was unaffected by TGF-β1. We used 9 
a chemically induced protein dimerization method to study the orientation of p22
phox
 and Nox4 in the 10 
endoplasmic reticulum membrane. This technique is based on the rapamycin-mediated heterodimerization 11 
of the mammalian FRB domain with the FK506 binding protein. The results of these experiments suggest 12 
that the enzyme complex produces H2O2 into the lumen of the endoplasmic reticulum, indicating that 13 
Nox4 contributes to the development of the oxidative milieu within this organelle. 14 
 15 
KEYWORDS : Reactive oxygen species / NADPH oxidase / Nox4 / Hydrogen peroxide / p22
phox
 16 
 17 
ABBREVIATIONS: 18 
 19 
Nox4: NADPH oxidase 4 20 
Nox2: NADPH oxidase 2 21 
Duox: dual oxidase 22 
TGF-1: transforming growth factor 1 23 
ROS: reactive oxygen species 24 
HPF: human pulmonary fibroblast 25 
TTF: tail-tip fibroblast 26 
FKBP: FK506 binding protein 27 
ERO1: ER oxidoreductin 1 28 
INTRODUCTION 1 
 2 
Regulated production of reactive oxygen species (ROS) is now considered an essential component 3 
of maintaining homeostasis of live organisms [22,29]. Among ROS, hydrogen peroxide (H2O2) has 4 
emerged as a particularly important molecule with pleiotropic functions that include roles in host defense, 5 
thyroid hormone production, synthesis of the extracellular matrix and signal transduction[22]. H2O2 is 6 
produced at different intracellular sites as a byproduct of various biochemical pathways, but regulated 7 
production of H2O2 is mediated by members of the Nox/Duox family of NADPH oxidases[16,22]. Nox2, 8 
the prototypic enzyme of this family, was originally identified in phagocytes, whereas non-phagocytic 9 
Nox/Duox isoforms are expressed and function in a wide variety of cells and tissues. 10 
Currently, the most intensively studied, dedicated ROS source is Nox4, which was originally 11 
identified in kidney epithelial cells[15,33]. Subsequent studies revealed that the expression of Nox4 is not 12 
restricted to the kidney, but other cells including endothelial and alveolar epithelial cells, osteoclasts, 13 
cardiomyocytes and activated fibroblasts also contain the enzyme[3]. The physiological function of Nox4 14 
remains unclear. Recent studies on knockout animals suggest that ROS production by Nox4 is often 15 
protective in different disease models[31,42], although pathogenic roles were also described for the 16 
enzyme[18,20].  17 
We know little about the regulation of Nox4. Several data suggest that the activity of Nox4 is 18 
regulated at the transcriptional level[7], but acute, hitherto unknown regulatory mechanisms might also 19 
exist. Nox/Duox proteins often interact with other partners to form fully active enzyme complexes[7]. 20 
Genetic evidence proves that p22
phox
, which was originally identified as a component of the phagocytic 21 
oxidase, also supports the biological activity of Nox3[25]. Furthermore, in heterologous expression 22 
systems, the activity of both Nox4 and Nox1 was stimulated by the co-expression of p22
phox
[1] [19,24]. In 23 
the majority of the Nox4-related studies, the activity and localization of the enzyme were analyzed in 24 
heterologous expression systems.  However, it remained unknown, whether the activity of Nox4 is also 25 
dependent on p22
phox
 in cells where these proteins are naturally co-expressed. Using genetically-modified 26 
cell models we demonstrate that endogenously expressed p22
phox
 is an essential component of the Nox4 27 
enzyme complex, and we demonstrate an asymmetrical relationship between the two proteins: the level of 28 
p22
phox
 is not influenced by Nox4 expression; however the stability of Nox4 is dependent on the presence 29 
of p22
phox
.  We also show that the Nox4-p22
phox
 complex localizes to the endoplasmic reticulum, and their 30 
membrane topology is compatible with ROS being released into the lumen of the endoplasmic reticulum.     31 
32 
 4 
EXPERIMENTAL PROCEDURES 1 
 2 
Materials 3 
The Alexa488 and 568-labeled goat monoclonal anti-mouse and polyclonal anti-rabbit Fab- 4 
antibodies were obtained from Life Technologies. The monoclonal anti-V5 antibody was purchased from 5 
AbD Serotec. The 16G7, IgG1-type monoclonal anti-p22
phox
 antibody was previously characterized by the 6 
authors[8]. The monoclonal anti-AU1 was obtained from Covance (AFC-130P), while the rabbit 7 
polyclonal was ordered from Abcam (ab3401). The monoclonal β-actin and all other chemicals were 8 
purchased from Sigma-Aldrich unless otherwise stated. Rapamycin was a kind gift of Péter Várnai. The 9 
anti-Nox4 antibody was obtained from Novus Biologicals. 10 
Cell culture 11 
Hela wt (ATCC: CCL-2™), dermal fibroblast (BJ, ATCC: CRL-2522™) and HEK293 FS cells 12 
were grown in DMEM (Lonza) supplemented with 10% fetal bovine serum (FBS), 50 U/mL penicillin and 13 
50 μg/mL streptomycin (Sigma-Aldrich). Human pulmonary fibroblasts (HPF, PromoCell, C-12360) were 14 
grown in fibroblast medium (PromoCell) supplemented with 2% FBS, 5 ng/mL Basic Fibroblast Growth 15 
Factor and 5 µg/mL insulin. Nox4-overexpressing HEK 293 FS cells were described in our previous 16 
report[12]. The fibroblasts of p22
phox
-mutant (nmf333)[25] and Nox4 knockout (3FAFyh) mice were 17 
generated from tail tips of 8-weeks-old animals. After 30 min collagenase digestion of the tail tips, cells 18 
were cultured in DMEM containing 10% FBS and 1%  penicillin/streptomycin for several days. Before 19 
TGF-β1 treatment, we serum.deprived the cells in the presence of 0.05% serum. Cells were treated with 20 
TGF-β1 (R&D Systems, Minneapolis, MN) for 24 h in the absence of serum. 21 
Animals 22 
 Nox4-deficient mice (strain 3FAFyh), obtained from the Biology Division of the Oak Ridge 23 
National Laboratory (Oak Ridge, TN), were identified within a group of homozygous-viable, radiation-24 
induced albino mice that lack the Tyrosinase (Tyr) color coat gene[30]. Nox4 and Tyr are adjacent gene 25 
sequences located on the q-arm (c-locus) of chromosome 7.  Southern blots probed with the full-length 26 
Nox4 cDNA confirmed the absence of the entire Nox4 genomic sequence.  PCR-based analysis was used 27 
to determine the boundaries of the mutated Nox4-Tyr locus, which revealed a deletion ~2100 kilobases in 28 
length.  Most of the deleted segment encompassed a region upstream of Nox4 that includes a cluster of 29 
olfactory-vomeronasal receptor genes and pseudogenes (Vmn2r-70 through Vmn2r-79) and folate 30 
hydrolase (Folh1), followed by Nox4 and Tyr. Intact Gmr5 and Ctsc genomic sequences were detected 31 
immediately distal to this deleted sequence. 32 
 p22
phox
-mutant (nmf333) mice were obtained from The Jackson Laboratory (Bar Harbor, ME). 33 
Animals were maintained on a standard diet and given water ad libitum. 34 
 5 
 1 
DNA constructs and transfection 2 
The p22
phox
-containing plasmids were generated by PCR based amplification of p22
phox
 ORF from 3 
human renal cDNA (Applied Biosystems/Ambion, Austin, TX, USA) with a forward primer pair 4 
containing a 5’ NheI and 3’ BamHI sites followed by a V5-epitope-encoding sequence to frame into 5 
pcDNA3.1 vector. The p22
phox
-AU1 epitope-tagged version was created with site-directed mutagenesis 6 
(QuikChange II Site-Directed Mutagenesis Kit, Agilent) by using primers containing the AU1-coding 7 
sequence. The V5-tagged Nox4 pcDNA3.1 plasmid was available in our lab, and it was used for further 8 
modification with different tags. N-terminal AU1 tag was introduced by site-directed mutagenesis. CFP-9 
FRB-HA-tag was amplified with NheI-BglII restriction sites by PCR from a pEGFP-based vector of P. 10 
Várnai [37] and ligated to the N-terminal site of Nox4. The p22
phox
-FRB-HA-CFP was generated by PCR 11 
amplification from the previous vector, with SalI-MfeI restriction sites to ligate into the C-terminal end of 12 
p22
phox
. The FRB-YFP plasmid was received from P. Várnai’s lab[37].  13 
Vectors encoding HyPer (cytosolic) described by Belousov et al.[4] were purchased from Evrogen 14 
(Moscow, Russia). The targeted versions of HyPer were formerly cloned and described by Enyedi et 15 
al.[13]. All constructs have been verified by DNA sequencing. 16 
Plasmids were transfected by using Lipofectamine LTX (Life Technologies) or with Neon 17 
Transfection System (Life Technologies) in the stage of 60-70% confluency. For gene silencing we 18 
applied standard siRNA treatment: we transfected 60-80% confluent, adherent cells with 25 pM specific 19 
or scrambled siRNA with Lipofectamine RNAiMAX (Life Technologies) according to the manufacturer's 20 
instructions. After transfection, the cells were incubated for further 2-3 days. 21 
Immunocytochemistry 22 
Cells were plated on coverslips were fixed in 4% paraformaldehyde in PBS, and then washed and 23 
quenched for 10 min in 100 mM glycine in PBS. After four times washing in PBS, cells were 24 
permeabilized in 1% BSA and 0.1% Triton X-100 in PBS for 20 min. We blocked the cells for 1 hour in 25 
3% BSA in PBS. Cells were subsequently incubated with primary antibody in 3% BSA-containing PBS 26 
for 1 or 2 hours, then washed in PBS several times. The secondary antibody was used for 1 hour in 3% 27 
BSA in PBS then washed in PBS again. After the final washing steps the cells were mounted with Mowiol 28 
4–88 antifade reagent [Tris (pH 8.5) and glycerol-based polyvinyl alcohol 4–88]. 29 
 30 
Western blot analysis 31 
In Western Blot experiments, cells were washed once with cold PBS, then lysed in RIPA buffer 32 
(50 mM Tris, 150 mM NaCl, 0.1% SDS, 0.5% Na-deoxycholate, 1% Triton-X) enriched with proteinase 33 
 6 
inhibitor cocktail (Roche Life Science) then were spun at 13400 rpm for 10 min. After that, the 1 
supernatant was combined with 4×Laemmli sample buffer [0.005% Bromophenol blue, 4% SDS, 20% 2 
glycerol, 0.1 M Tris (pH 6.8)] then loaded without boiling on 12% SDS–polyacrylamide gels. After 3 
electrophoresis, the gels were blotted onto nitrocellulose membranes, blocked in 5% milk powder 4 
containing PBS for 1 hour or overnight. The primary antibody was incubated for 1 hour in 3% BSA-5 
containing PBS at room temperature. The binding was visualized by peroxidase-coupled goat anti-mouse 6 
or anti-rabbit IgG (GE Healthcare), using the enhanced chemiluminescence method (Millipore). 7 
 8 
Fluorescent intensity measurements and confocal microscopy 9 
Immunostained cell images were collected on a Zeiss LSM710 confocal laser scanning 10 
microscope equipped with a 63x1.4 oil immersion numerical aperture plan Apochromat objective (Zeiss). 11 
Images were acquired from optical slices of 1–2 μm thickness. Alexa488 immunofluorescence detection 12 
involved excitation with a 488 nm argon laser, while in case of Alexa568 the 543 nm helium/neon laser 13 
was applied. Emissions were collected using a 500-530 nm band-pass filter and Alexa488 and a 560 nm 14 
long-pass filter for Alexa568. Image analysis was performed using Zen software (Zeiss).The ratiometric 15 
measurements of HyPer were performed on an inverted microscope (Axio Observer, Zeiss) equipped with 16 
40x1.4 oil-immersion objective (Fluar, Zeiss) and a Cascade II. camera (Photometrics, Tucson, AZ). 17 
Excitation wavelengths were set by a random-access monochromator connected to a xenon arc lamp 18 
(DeltaRAM, Photon Technology International, Birmingham, NJ). The excitation wavelengths of HyPer 19 
are 490 and 420 nm combined with a 505 nm dichroic filter and a 525/36 nm emission filter set. Data 20 
acquisition was handled by Metafluor software (Molecular Devices, Downingtown, PA). Ratios were 21 
calculated upon background fluorescence subtraction. We applied FKBP12-FRB system as a chemically 22 
inducible translocation assay with rapamycin as an inducer. Within a cell, after administration of 300nM 23 
rapamycin, the molecule first binds to FKBP12 (12-kDa FK506-binding protein) and only then the 24 
FKBP12–rapamycin complex binds to FBR, which is the FKBP and rapamycin binding domain of  TOR 25 
kinase[28,37]. BJ fibroblasts were plated in six-well dishes at 60% confluence and cotransfected the CFP-26 
FKBP12-Nox4 or p22phox-FKBP12-CFP with FRB-YFP together with electroporation. Kinetic 27 
measurements were performed at cell chamber (AttoFluor, Life Technologies) containing coverslips at 28 
room temperature in 1 ml HEPES-buffered medium (H-medium), where stimuli were added in 0.1 ml of 29 
H-medium. Images were acquired every 5-10 seconds for a period of 15 min. 30 
 31 
In situ hybridization 32 
Animals were sacrificed by decapitation, the kidneys were removed and frozen on dry ice. 12 µm-33 
thick sections were cut in a cryostat (Leica Microsystems GmbH, Wetzlar, Germany) and mounted onto 34 
 7 
positively charged Superfrost Plus slides (Life Technologies Magyarország Kft, Budapest, Hungary). To 1 
create templates for probe synthesis, the full coding sequence of the mouse p22
phox
 cDNA and a DNA 2 
fragment composed of the last 300 bps of the murine Nox4 coding sequence were subcloned into PCR 4.0 3 
TOPO vector (Life Technologies). Hybridizations were performed with 10
6
 cpm/slide of the [35S]UTP-4 
labeled (Per-Form Hungaria Kft, Budapest, Hungary) antisense and sense riboprobes, prepared according 5 
to the MAXIscriptT7/T3 Transcription Kit (Life Technologies), overnight at 55°C. Next day the slides 6 
were washed, dehydrated and dipped into NTB nuclear track emulsion (Carestream Health Deutschland 7 
GmbH, Stuttgart, Germany) for 3 days. Emulsion-coated slides were developed using Kodak Dektol 8 
developer and Fixer (Sigma-Aldrich Kft, Budapest, Hungary). Sections were counter-stained with 0.5% 9 
Giemsa solution (Sigma), air dried and coverslipped using Cytoseal 60 mounting medium (Stephens 10 
Scientific, Riverdale, NJ, USA). 11 
 12 
 13 
Amplex Red assay for extracellular H2O2 level quantification 14 
The extracellular H2O2 levels were measured with Amplex Red method (Life Technologies). 15 
Adherent confluent cells were incubated in the presence of 50μM Amplex red and 0.1 U/ml horseradish 16 
peroxidase in H-medium. After 40 min incubation at 37°C, resorufin fluorescence was measured at 590 17 
nm.  18 
Statistics 19 
Data are presented as mean ± S.E.M unless otherwise stated. Statistical analyses were performed 20 
using Sigmaplot 13.0 software for Windows (Systat Software Inc.). For estimating the significance of 21 
differences Student's t-test or Mann-Whitney-U test was used. 22 
 23 
RESULTS 24 
 25 
TGF-β1-induced H2O2 production of primary fibroblasts is dependent on Nox4- and p22
phox
 26 
expression 27 
 28 
Since TGF-β1 was described to stimulate Nox4-dependent H2O2 production [23] and this response seems 29 
to have multiple roles in TGF-β1 signaling [9] [6,10], we decided to study the role of p22phox in primary 30 
human and mouse fibroblasts stimulated by TGF-β1. As shown in Fig. 1, treatment of human pulmonary 31 
(HPF) or foreskin-derived (BJ) fibroblasts with TGF-β1 for 24 h lead to increased H2O2 production. 32 
Experiments using Nox4-specific siRNAs confirmed that Nox4 was responsible for the increased ROS 33 
output (Figs. 1A and 1B).  34 
 8 
The participation of Nox4 in TGF-β1-stimulated H2O2 release has not yet been confirmed by 1 
experiment on gene-deficient cells, thus we prepared tail-tip fibroblasts (TTFs) form Nox4 knockout and 2 
wild-type animals and studied the effect of TGF-β1 on the H2O2 output of the cells. TGF-β1 effectively 3 
stimulated the H2O2 production of wild-type cells, but Nox4-deficient fibroblasts failed to exhibit 4 
enhanced ROS production (Fig. 2A). This result clearly suggested the essential role of Nox4 in the ROS 5 
response. Next, we wanted to assess the importance of p22
phox
 in the TGF-β1-stimulated H2O2 response. 6 
To achieve this, we prepared TTFs from the nmf333 strain mice that carry a mutation in the CYBA 7 
gene[25], leading to instability of the encoded protein. This mutation was described to result in a 8 
decreased Nox2-mediated ROS production in neutrophil granulocytes[25]. Fig. 2B shows that TGF-β1-9 
treated p22
phox
-deficient TTFs released significantly less H2O2 than cells prepared from wild-type 10 
littermates. This experiment proved that endogenously expressed p22
phox
 supports the activity of Nox4. 11 
 12 
The expression of p22
phox
 in primary fibroblasts is independent of Nox4 13 
 14 
According to our current understanding, Nox4 is mainly regulated at the level of gene transcription, and 15 
the stimulatory effect of TGF-β1 is a consequence of increased Nox4 expression[7]. We wanted to know, 16 
whether TGF-β1 also stimulates the expression of p22phox that proved to be an essential partner of Nox4 in 17 
previous experiments. After exposure to TGF-β1 for 24 h, we observed the induction of Nox4 mRNA 18 
expression in both HPFs and BJ fibroblasts (Fig. 3A). Interestingly, the expression of p22
phox
 mRNA in 19 
the same cell types was unaffected by TGF-β1 (Fig. 3A). In further experiments, we analyzed the p22phox 20 
protein content of control- and TGF-β1-stimulated HPFs and BJ fibroblasts. These experiments revealed 21 
that the p22
phox
 protein is already expressed in unstimulated cells, and its level remains constant following 22 
TGF-β1 treatment (Fig. 3B). We also studied p22phox expression levels in a cell line where Nox4 was 23 
heterologously expressed [12]. Fig. 3C (right panel) shows a marked increase in H2O2 production by 24 
Nox4-expressing cells, whereas the p22
phox
 content of the Nox4-expressing and parent cell line was 25 
essentially the same (Fig. 3C, left panel). In subsequent experiments, we compared the p22
phox
 expression 26 
of wild-type and Nox4-deficient TTFs. As shown in Fig. 3D, the p22
phox
 protein was present in the genetic 27 
absence of Nox4 and its level was unaffected by TGF-β1. Altogether, the results of the above-described 28 
experiments suggested that the expression of p22
phox
 is independent of Nox4, and complex formation with 29 
Nox4 is not required for p22
phox
 stabilization.  30 
 31 
Nox4  is stabilized by p22
phox
 in the kidney 32 
 33 
 9 
Next, we wanted to examine whether the presence of p22
phox
 is required for the expression of the Nox4 1 
protein or it regulates Nox4 activity by other means. Since we could not detect Nox4 at the protein level in 2 
TGF-β1-stimulated fibroblasts, we decided to study the interaction between the two proteins in the kidney 3 
that shows the highest Nox4 level among mammalian organs[15]. First, we checked whether Nox4 and 4 
p22
phox
 are expressed in the same region of the kidney. In situ hybridization experiments confirmed that 5 
Nox4 and p22
phox
 mRNAs are both present in proximal tubules epithelial cells (Figs. 4A-D). Next, we 6 
studied the p22
phox
 content of kidney lysates from wild-type, p22
phox
 mutant (nmf333) and Nox4-deficient 7 
animals. As shown in Fig. 4E the level of p22
phox
 was unaffected in the absence of Nox4, whereas p22
phox
 8 
mutation resulted in reduced protein level. When the expression of Nox4 was analyzed in the same 9 
samples we found Nox4 to be absent in both p22
phox
 mutant and Nox4-deficient kidney lysates (Fig. 4F). 10 
This observation suggests that p22
phox
 is essential for the stabilization of Nox4 in kidney epithelial cells.  11 
 12 
Nox4 and p22
phox
 localize to the endoplasmic reticulum of primary fibroblasts 13 
 14 
Since our previous experiments revealed an intimate relationship between p22
phox
 and Nox4, we wanted to 15 
determine the intracellular localization of p22
phox
 in primary fibroblasts. Unfortunately, none of the tested 16 
p22
phox
-specific antibodies gave specific labeling; thus, we added a V5 epitope to the C-terminus of 17 
p22
phox
 and studied the distribution of the labeled protein. Fig. 5A shows that p22
phox
-V5 localized to the 18 
endoplasmic reticulum in BJ fibroblasts. This staining pattern was not due to the modification of the C-19 
terminal part of p22
phox
 since introducing a different (AU1) tag into the protein did not change the 20 
characteristic localization pattern (data not shown). As we demonstrated in earlier experiments, Nox4 was 21 
absent in unstimulated primary fibroblasts. Therefore, it was possible that localization of p22
phox
 to the ER 22 
did not represent the final position of the protein in the Nox4 enzyme complex. We, therefore, tested 23 
whether the subcellular distribution of p22
phox
 changes upon TGF-β1 stimulation, e.g. under conditions 24 
when Nox4 becomes induced. As shown in Fig. 5A, TGF-β1 treatment did not modify the localization of 25 
p22
phox
 that remained in the endoplasmic reticulum. When an epitope-labeled version Nox4 was 26 
introduced into fibroblasts by heterologous expression, it was also detected in the ER, where it co-27 
localized with BiP (Fig. 5B). These observations suggested that the physiological location of the p22
hox
-28 
Nox4 complex in primary fibroblasts is the ER. 29 
 30 
Orientation of p22
phox
 and Nox4 in the endoplasmic reticulum membrane 31 
 32 
H2O2 production by Nox4 in TGF-β1-stimulated fibroblasts is readily detected in the extracellular space, 33 
although the enzyme complex localizes to an intracellular compartment. We, therefore, became interested 34 
 10 
in determining the orientation of the Nox4-p22
phox 
complex in the ER membrane. To study the orientation 1 
of p22
phox
, we applied a chemically induced protein dimerization technique, which is based on the 2 
rapamycin-induced heterodimerization of the mammalian FRB domain with the FK506 binding 3 
protein[28,37]. We coupled FRB along with the Cyan Fluorescent Protein (CFP) to the C-terminus of 4 
p22
phox
 and FKB12 was labeled with the Yellow Fluorescent Protein (YFP). Fig. 6A shows that the FRB-5 
CFP labeled p22
phox
 localized to the ER, whereas the FKB12-YFP protein was cytosolic (Fig. 6B). After 6 
the addition of rapamycin the FKB12-YFP protein rapidly relocated to the ER indicating that the 7 
dimerization event occurred on the cytosolic surface of the ER (Fig. 6D). In other experiments, we 8 
introduced the FRB-CFP tag to N-terminus of Nox4. This Nox construct also located to ER and following 9 
the addition of rapamycin, the YFP-linked FKBP12 showed colocalization with Nox4 (Fig. 6H). Based on 10 
these experiments, the orientations of p22
phox
 and Nox4 are compatible with ROS release into the lumen of 11 
the endoplasmic reticulum (Figs. 6I and J).  12 
 13 
 14 
DISCUSSION 15 
 16 
Nox4 is currently the most intensively studied regulated source of hydrogen peroxide. Although 17 
Nox4 was originally identified in the kidney [15,33], Nox4-dependent production of ROS is now 18 
recognized in several other tissues and cells. The great majority of Nox4-related studies aimed to identify 19 
the physiological and pathological roles of Nox4-derived H2O2. Thus, we still know little about the protein 20 
interactions and regulation of Nox4 [7,34]. The intracellular localization of Nox4 is also obscure since the 21 
enzyme was detected at several different intracellular locations [5,17,21,39,41].  22 
In this work, we characterized the expression and function of p22
phox
 in primary fibroblasts and 23 
kidney, i.e. at locations where Nox4 is also endogenously expressed. Our experiments revealed an 24 
interesting asymmetrical relationship between p22
phox
 and Nox4. We found p22
phox
 to be expressed in the 25 
absence of Nox4 in both fibroblasts and the kidney, but the presence of p22
phox
 was required for the 26 
activity of Nox4. Since Nox4 protein was not detected in kidney lysates of p22
phox 
mutant animals, we can 27 
conclude that p22
phox
 is required for the stabilization of Nox4.  28 
p22
phox
 was first identified as an essential membrane component of the phagocytic oxidase, where 29 
together with Nox2 they form the cytochrome b558 complex[26,32]. According to our current view of the 30 
phagocytic oxidase, cytochrome b558 catalyzes the final steps of electron transfer during superoxide 31 
production. P22
phox
 was also described as an essential component of an NADPH oxidase expressed in 32 
vascular smooth muscle cells, but the identity of the partner Nox isoform was unknown at the time [36]. 33 
Genetic evidence supports the cooperation between p22
phox
 and Nox3, as mice with a mutant p22
phox
 gene 34 
 11 
exhibit a vestibular defect that is similar to the one observed in Nox3-deficient animals[25]. In 1 
heterologous expression models, p22
phox
 was also found to interact with and support the activity of 2 
Nox4[1,24] [19], however, our data obtained from experiments on p22
phox
-mutant fibroblasts provide 3 
genetic evidence for the importance of p22
phox
 in the stabilization of endogenously expressed Nox4. The 4 
nmf333 mutation results in a Y121H amino acid substitution in p22
phox
[25]. When the effect of this amino 5 
acid change on Nox4 function was tested in a heterologous expression system, the stimulatory effect of the 6 
mutant p22
phox 
protein was indistinguishable from the effect of its wild-type counterpart[38]. In a different 7 
study on Nox4-transfected HEK293 cells, the expression level of Nox4 was not affected by silencing 8 
p22
phox
 [19]. The difference between these data and our results obtained from experiments on primary 9 
cells emphasizes the importance of cautious interpretation of data derived from heterologous expression 10 
systems. 11 
In phagocytic cells, the presence of p22
phox
 is essential for the stabilization of Nox2, and p22
phox 12 
protein is detected only in the presence of Nox2, thus the simultaneous expression of both proteins is 13 
necessary for the appearance of the cytochrome b558 complex[27,35]. Stabilization of the p22
phox
 protein 14 
by Nox4 was also reported in HEK293 cells transfected with epitope-tagged Nox4- and p22
phox
 constructs 15 
[1]. However, several of our observations suggest that the symmetrical relationship between p22
phox
 and 16 
Nox2 is not characteristic of the Nox4 system. First, we detected p22
phox
 by Western blot in human 17 
pulmonary and foreskin fibroblasts that did not express any Nox proteins. TGF-β1 treatment of these cells 18 
boosted the expression of Nox4 and consequent ROS production, but the p22
phox
 content of TGF-β1-19 
treated cells did not differ from that of control, unstimulated cells. Furthermore, p22
phox
 was also detected 20 
in Nox4-deficient TTFs, confirming that the presence of Nox4 is not required for the stabilization of 21 
p22
phox
. It will be interesting to study whether this asymmetrical relationship between the two proteins is a 22 
unique feature of the Nox4 system or other Nox proteins (Nox1 and Nox3) behave similarly in cells where 23 
they are endogenously expressed. 24 
It is noteworthy that we could not study the effect of p22
phox
 on Nox4 expression in TGF-β1-25 
stimulated fibroblasts because we were unable to detect Nox4 at the protein level in these cells. When we 26 
compared the p22
phox
 content of primary fibroblasts and neutrophil granulocytes, we observed a much 27 
higher p22
phox
 content in neutrophils than in fibroblasts (Fig. S1). Since Nox proteins are supposed to form 28 
a 1:1 complex with p22
phox
, the p22
phox
 content of fibroblasts may limit the maximum of Nox4 expression. 29 
Apparently, this expression level is too low to be captured by anti-Nox4 antibodies which were tested 30 
during the course of our studies.  This observation cautions for the critical interpretation of experiments 31 
where Nox4 is detected at the protein level by Western blot analysis.  32 
The subcellular localization of Nox enzymes is one of the most important issues in the Nox/Duox 33 
research field. To know the specific intracellular sites of Noxes is critical because the highly reactive 34 
 12 
species produced by these enzymes unlikely travel a long distance before exerting their effects; thus their 1 
intracellular localization is a major determinant of their affected targets[40]. In previous works Nox4 was 2 
detected at various intracellular locations including the plasma membrane, nucleus, mitochondria, 3 
endoplasmic reticulum, and focal adhesions [5,17,21,39,41]. It is possible that the subcellular distribution 4 
of Nox4 is cell type-specific, however, the lack of specific antibodies might also explain the observed 5 
differences. According to our results, p22
phox
 resides in the endoplasmic reticulum of primary fibroblasts 6 
and this localization persists during myofibroblastic differentiation, e.g. when Nox4 becomes expressed in 7 
the cells. The localization of p22
phox  
likely defines the site of the Nox4-p22
phox
 complex, which in the case 8 
of TGF-β1-stimulated fibroblasts, appears to be the ER. Although we could not locate p22phox in the 9 
murine kidney by immunostaining, cell fractionation experiments suggest that protein – along with Nox4 10 
– is enriched in the microsomal fraction of the cells (data not shown).  11 
According to the current topological model of p22
phox
, which was described in phagocytic cells, 12 
the protein has two transmembrane domains with both termini facing the cytosol. Our data obtained by 13 
rapamycin-induced dimerization technique suggests that p22
phox
 resides in the ER membrane in a similar 14 
fashion, that is N- and C-termini located on the cytoplasmic side. This membrane topology would be 15 
compatible with H2O2 being released into the ER lumen. The ER lumen is characterized by a highly 16 
oxidative environment, which is probably due to the activity of the protein folding machinery. The 17 
oxidized state of the ER of primary fibroblasts was readily detected by an ER-targeted, redox-sensitive 18 
protein sensor, Hyper (data not shown). However, the already oxidized sensor would unlikely capture the 19 
presence of “extra” oxidants in the ER lumen. On the other hand, Nox4-derived H2O2 production by TGF-20 
β1-activated cells was readily detected in the extracellular space, confirming earlier observations, where 21 
Nox4 was described to produce mainly H2O2 [11]. At the first sight, the localization of Nox4 in the ER 22 
does not seem to be compatible with ROS release to the extracellular space, however, the intimate 23 
relationship between the ER and the plasma membrane can explain the extracellular detection of Nox4-24 
produced H2O2.  25 
The function of Nox4 in TGF-β1-stimulated fibroblasts is still incompletely understood. In a 26 
previous study, where RNAi was used to suppress Nox4 activity, the enzyme was found to promote 27 
myofibroblastic differentiation [9]. On the other hand, experiments on Nox4 knockout mice did not 28 
support a role of Nox4 in the development of kidney fibrosis [2] and we did not observe altered fibroblast-29 
myofibroblast transition in Nox4-deficient TTFs (data not shown). In more recent studies on vascular 30 
smooth muscle cells, Nox4 activity was found to have a role in TGF-β1-induced palladin expression [23] 31 
and focal adhesion formation [10]. This latter response seems to be dependent on the interaction of Hic-5 32 
and HSP27, indicating a complex role for Nox4-derived ROS in the organization of cytoskeletal responses 33 
[14].   34 
 13 
The formation and regulation of the redox environment in the ER is very complex and remains 1 
partially unexplored.  According to our current understanding of the ER redox machinery, the major 2 
source of H2O2 in the ER is ERO1 which produces H2O2 during the oxidation of PDI. Thus, the production 3 
of H2O2 in the ER is essentially thought to be a byproduct of oxidative protein folding. The addition of a 4 
dedicated H2O2 source to this scene appears to indicate redundancy, however, the redox milieu of the ER 5 
is unlikely homogenous, and it is possible that different ROS sources are compartmentalized within the 6 
organelle. Hopefully, the future identification of Nox4 targets will improve our understanding of the 7 
Nox4-p22
phox
 complex role in ER redox homeostasis. 8 
 9 
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LEGENDS TO FIGURES 16 
 17 
Figure 1.  18 
TGF-β1 stimulates H2O2 production in human primary dermal and pulmonary fibroblasts. 19 
Extracellular H2O2 production by adherent human pulmonary (HPF, A) and foreskin (BJ, B) fibroblasts, 20 
was determined by Amplex Red assay in the presence of 50 µM Amplex Red and 0.1 U/ml horseradish 21 
peroxidase in H-medium. After 40 min incubation at 37°C, resorufin fluorescence was measured at 590 22 
nm.  HPF. Cells were treated with Nox4 or control (scrambled) siRNA for 24 h and were stimulated with 23 
5 ng/mL TGF-β1 in serum-free medium for 24 h. Bars with SEM represent mean values of 3 independent 24 
experiments. ** P<0.001 * P<0.002 in Mann-Whitney U test or t-test. 25 
 26 
Figure 2.  27 
TGF-β1-stimulated H2O2 production by wild-type, NOX4- and p22
phox
- deficient tail tip fibroblasts. 28 
Serum-depleted, adherent, tail tip fibroblasts (TTFs) were treated with 5 ng/mL TGF-β1 for 24 h. 29 
Extracellular H2O2 production was measured by the Amplex Red assay in Nox4-deficient (A) and p22
phox–30 
mutant cells (B). Bars with SEM represents mean values in 3 independent experiments. ** P<0.001, * 31 
P<0.002 in t-test  32 
 33 
Figure 3.  34 
P22
phox
 mRNA and protein expression in primary fibroblasts and Nox4-transfected HEK293 cells  35 
 18 
(A). Nox4 and p22
phox
 mRNA expression levels of control and TGF-β1-induced HPFs, and BJ fibroblasts 1 
were determined after a 24 h treatment with TGF-β1. Relative expressions are expressed, where the non-2 
induced expressions are defined as 1.  (B). Western blot analysis of the p22
phox
 protein content of control 3 
and TGF-β1-stimulated HPFs and BJ fibroblasts. (C). Western blot analysis of the p22phox protein content 4 
in lysates of Nox4-expressing and control (untransfected) HEK293 FS cells. The right panel shows the 5 
H2O2 output of Nox4-expressing and control cells,  assessed by the Amplex Red assay. Western blot 6 
experiments yielded essentially the same result in at least three separate experiments.   Mean values and 7 
SEM are calculated from 3 independent experiments* P<0.005 in Paired t-test. (D). p22
phox
 protein 8 
expression of unstimulated and TGF-β1-induced TTFs, isolated from Nox4 knockout animals.   9 
 10 
Figure 4.  11 
Nox4 and p22
phox
 expression in the kidneys of wild-type, Nox4-knockout, and p22
phox
-deficient mice  12 
(A-D) In situ hybridization for Nox4 and p22
phox
 mRNAs in mouse kidney. (A, C: antisense probes, B, D: 13 
sense probes, PT: proximal tubule, DT: distal tubule). (E) Analysis of p22
phox
 expression by Western blot 14 
in kidney lysates from wild-type, p22
phox
 mutant (nmf333) and Nox4-deficient animals. (F) Nox4 protein 15 
detection by Western blot in kidney lysates from wild-type, p22
phox
 mutant (nmf333) and Nox4-deficient 16 
animals. 17 
 18 
Figure 5. 19 
Subcellular localization of  Nox4 and p22
phox
 in BJ fibroblasts 20 
Representative confocal images of permeabilized BJ cells expressing V5-tagged p22
phox
 (A) and Nox4 (B) 21 
compared to endogenous BiP. Fibroblasts were transiently transfected then induced with TGF-β1 or left 22 
untreated after overnight serum depletion. The cells were fixed and immunostained with anti-V5 and anti-23 
BiP antibody. Bars represent 10 μm.  24 
 25 
 26 
Figure 6.  27 
Translocation of FKBP12 domain upon heterodimerization with FRB in dermal fibroblasts. 28 
The rapamycin-induced heterodimerization of the mammalian FRB domain with FK506 binding protein 29 
12 (FKBP12) can be followed in confocal images. The p22
phox
-FRB-CFP (A) or CFP-FRB-Nox4 (B) and 30 
YFP-linker-FKBP12 were cotransfected in BJ fibroblasts. After 24h incubation, the cells were seated in 31 
cell chamber with H-medium in the confocal microscope. Administration of 300 nM rapamycin, induced 32 
the translocalization of the FKBP12 to reach the spatially available FRB domain. Bars represent 10 μm. 33 
The schematic structure of the p22
phox
 and Nox4 is shown in panels C and D.  34 
 19 
Figure S1 1 
Comparison of the p22
phox
 content of neutrophils and primary fibroblasts 2 
Western blot analysis of the p22
phox
 protein content of different numbers of neutrophils (PMN) human 3 
pulmonary (HPF) and dermal (BJ) fibroblasts.  4 
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